Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors. (Q54302909)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

oral squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

E Vigarios

1

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

L Lamant

2

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

J P Delord

3

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

J C Fricain

4

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

C Chevreau

5

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

B Barrés

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

C Gomez-Roca

7

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

M Boulanger

8

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

V Sibaud

9

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

language of work or name

0 references

publication date

19 April 2015

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

172

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

6

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

1680-1682

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

Analysis of dermatologic events in vemurafenib-treated patients with melanoma

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities.

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

RAS mutations are associated with the development of cutaneous squamous cell tumors in patients treated with RAF inhibitors

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

Diverse cutaneous side effects associated with BRAF inhibitor therapy: a clinicopathologic study

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

No human virus sequences detected by next-generation sequencing in benign verrucous skin tumors occurring in BRAF-inhibitor-treated patients

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

Vemurafenib cooperates with HPV to promote initiation of cutaneous tumors

1 reference

https://api.crossref.org/works/10.1111/BJD.13610

21 January 2018

Identifiers

10.1111/BJD.13610

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 May 2018

http://europepmc.org/abstract/MED/25495246

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54302909&oldid=1697177168"